Company / SG&A Expense
Lucid Diagnostics Inc. SG&A Expense History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$19.3M
FY2024
5-year range
$7.0K / $24.0M
FY2021-FY2024
Trend
-19.7%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $21,000 to $19M over the past 2 years.
Based on SEC 10-K filings.
$19M in FY2024.
Increased from $21,000 to $19M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, sg&a expense decreased 19.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -4.82 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $19.3M | -19.7% |
| FY2023 | $24.0M | +114061.9% |
| FY2022 | $21.0K | +200.0% |
| FY2021 | $7.0K | - |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 24, 2026